-
IntroducedMar 16, 2020
-
Passed Senate
-
Passed Assembly
-
Signed into Law
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Last Action See all actions
Senate • Jun 03, 2021: Substituted by A277 (1R)
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on S 2035
Tweets
Whip Lists
Sponsors
Votes
Actions
- Jun 03, 2021 | Senate
- Substituted by A277 (1R)
- Feb 09, 2021 | Senate
- Reported from Senate Committee with Amendments, 2nd Reading
- Mar 16, 2020 | Senate
- Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
×
Try FastDemocracy Professional
Try FastDemocracy Professional
Are you part of a non-profit, business, government relations firm or association? We can take your advocacy to the next level!
Report a comment
×
Do you want to add this event to your calendar?